簡介

本頁面提供了有關 William M Mitchell 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示William M Mitchell已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:AIM / AIM ImmunoTech Inc. Director 521,723
如何解讀這些圖表

以下圖表顯示了在William M Mitchell進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 William M Mitchell 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-04-23 2025-04-11 4 AIM AIM ImmunoTech Inc.
Common Stock
P - Purchase 196,851 521,723 60.59 0.03 5,000 13,252
2025-03-18 2025-03-14 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award 44,899 324,872 16.04 0.12 5,208 37,685
2025-03-04 2025-02-28 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award 38,580 279,973 15.98 0.14 5,208 37,796
2025-02-20 2025-01-15 4/A AIM AIM ImmunoTech Inc.
Common Stock
A - Award 27,412 172,266 18.92 0.19 5,208 32,731
2025-02-20 2025-02-14 4/A AIM AIM ImmunoTech Inc.
Common Stock
A - Award 43,330 241,393 21.88 0.12 5,208 29,015
2025-02-20 2025-01-31 4/A AIM AIM ImmunoTech Inc.
Common Stock
A - Award 25,797 198,063 14.98 0.20 5,208 39,989
2025-02-19 2025-02-14 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award -43,330 241,393 -15.22 0.12 -5,208 29,015
2025-02-03 2025-01-31 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award -25,797 198,063 -11.52 0.20 -5,208 39,989
2025-01-17 2025-01-15 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award -27,412 172,226 -13.73 0.19 -5,208 32,723
2025-01-03 2024-12-31 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award 26,305 144,854 22.19 0.20 5,208 28,681
2024-12-20 2024-12-19 4 AIM AIM ImmunoTech Inc.
Common Stock
S - Sale -4,580 118,549 -3.72 0.19 -884 22,880
2024-12-17 2024-12-13 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award 24,452 123,803 24.61 0.21 5,208 26,370
2024-12-03 2024-12-02 4 AIM AIM ImmunoTech Inc.
Common Stock
A - Award 22,645 99,351 29.52 0.23 5,208 22,851
2022-03-04 2022-03-03 4 AIM AIM ImmunoTech Inc.
Options
A - Award 50,000 50,000
2021-11-15 2021-11-11 4 AIM AIM ImmunoTech Inc.
Options
A - Award 50,000 50,000
2020-08-14 2020-08-12 4 AIM AIM ImmunoTech Inc.
Options
A - Award 50,000 50,000
2019-12-16 2019-12-13 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 8,358 76,407 12.28 0.45 3,801 34,750
2019-12-02 2019-11-29 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 9,503 68,049 16.23 0.40 3,801 27,220
2019-11-18 2019-11-15 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 8,264 58,546 16.44 0.46 3,801 26,931
2019-11-01 2019-10-31 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 7,603 50,282 17.81 0.50 3,802 25,141
2019-10-17 2018-10-17 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 6,911 42,679 19.32 0.55 3,801 23,473
2019-10-04 2019-10-02 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 5,002 35,768 16.26 0.76 3,802 27,184
2019-09-18 2019-09-16 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 2,033 30,766 7.08 1.87 3,802 57,532
2019-09-05 2019-09-03 4 AIM AIM ImmunoTech Inc.
Common Stock
J - Other 2,112 28,733 7.93 1.80 3,802 51,719
2019-08-20 2019-08-16 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 2,001 26,621 8.13 1.90 3,802 50,580
2019-08-02 2019-07-31 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 1,618 24,620 7.03 2.35 3,802 57,857
2019-07-18 2019-07-16 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 920 22,624 4.24 4.13 3,800 93,437
2019-07-08 2019-07-03 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 866 21,704 4.16 4.39 3,802 95,281
2019-06-24 2019-06-21 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
P - Purchase 9,677 20,838 86.70 4.03 38,998 83,977
2019-06-18 2019-05-09 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
C - Conversion 140,000 459,805 43.78
2019-06-18 2019-03-18 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
C - Conversion 200,000 319,805 166.94
2019-06-18 2019-06-14 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 711 11,161 6.80 5.35 3,804 59,711
2019-06-14 2019-06-03 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 38,013 119,805 46.48 0.10 3,801 11,980
2019-06-14 2019-05-16 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 25,342 81,792 44.89 0.15 3,801 12,269
2019-06-14 2019-05-06 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 18,101 56,450 47.20 0.21 3,801 11,854
2019-06-14 2019-05-03 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
J - Other 27,152 38,349 242.49 0.14 3,801 5,369
2019-03-13 2019-03-04 4 HEB HEMISPHERX BIOPHARMA INC
Subr Rights(to buy)
X - Other 40 0 -100.00 1,000.00 40,000
2019-03-13 2019-03-04 4 HEB HEMISPHERX BIOPHARMA INC
Warrants
X - Other 200,000 200,000
2019-03-13 2019-03-04 4 HEB HEMISPHERX BIOPHARMA INC
Series B Convertible Preferred Stock
X - Other 40 40
2019-01-30 2019-01-28 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 50,000 50,000
2019-01-30 2019-01-28 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 207,343 207,343
2018-11-29 2018-11-27 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
A - Award 2,500 11,197 28.75
2018-10-19 2018-10-17 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 172,786 172,786
2018-07-20 2018-07-18 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 98,098 98,098
2018-05-18 2018-05-16 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 100,000 100,000
2018-05-18 2018-05-16 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 152,053 152,053
2018-04-19 2018-04-12 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 100,000 100,000
2018-03-01 2018-02-13 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 226,023 226,023
2017-09-01 2017-08-31 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 29,757 29,757 0.26 7,737 7,737
2017-08-16 2017-08-15 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 25,953 25,953 0.29 7,526 7,526
2017-08-01 2017-07-31 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 25,284 25,284 0.30 7,585 7,585
2017-07-17 2017-07-15 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 22,047 22,047 0.34 7,496 7,496
2017-07-05 2017-06-30 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 17,290 17,290 0.44 7,608 7,608
2017-06-26 2017-06-15 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 17,287 17,287 0.44 7,606 7,606
2017-06-26 2017-05-31 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 14,361 14,361 0.53 7,611 7,611
2017-06-26 2017-05-15 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 13,238 13,238 0.57 7,546 7,546
2017-06-26 2017-04-30 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
A - Award 12,644 12,644 0.60 7,586 7,586
2016-07-29 2016-07-29 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 11,696 11,696 0.13 1,520 1,520
2016-07-19 2016-07-15 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 12,671 12,671 0.12 1,521 1,521
2016-07-01 2016-06-30 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 12,671 12,671 0.12 1,521 1,521
2016-06-23 2016-06-21 4 HEB HEMISPHERX BIOPHARMA INC
Options to Buy Common Stock
A - Award 150,000 150,000
2016-06-16 2016-06-15 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 13,823 13,823 0.11 1,521 1,521
2016-06-02 2016-05-31 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 12,671 12,671 0.12 1,521 1,521
2016-05-16 2016-05-15 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 13,823 13,823 0.11 1,521 1,521
2016-05-03 2016-04-30 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 10,861 10,861 0.14 1,521 1,521
2016-04-19 2016-04-15 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 10,861 10,861 0.14 1,521 1,521
2016-04-06 2016-03-31 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 11,696 11,696 0.13 1,520 1,520
2016-04-06 2016-03-15 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 9,503 9,503 0.16 1,520 1,520
2016-04-06 2016-02-29 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 10,137 10,137 0.15 1,521 1,521
2016-04-06 2016-02-15 4 HEB HEMISPHERX BIOPHARMA INC
Incentive Rights
A - Award 12,671 12,671 0.12 1,521 1,521
2015-03-24 2015-03-20 4 HEB HEMISPHERX BIOPHARMA INC
Common Stock
G - Gift 50,663 199,661 34.00
2014-09-09 2014-09-08 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
J - Other 50,000 562,000 9.77
2013-08-02 2013-08-02 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
J - Other 150,000 562,000 36.41
2012-06-07 2012-06-05 4 HEB HEMISPHERX BIOPHARMA INC
Options to buy Common Stock
J - Other 100,000 412,000 32.05
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)